Covered recipient · General Payments record
WILLIAM MILLER
Podiatric Medicine & Surgery Service Providers Podiatrist Foot Surgery
General Payments · PY2018–2024
$1,797.18
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $636.27 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ORGANOGENESIS INC. | $209.62 | 5 |
| Amgen Inc. | $151.18 | 7 |
| ConvaTec Inc. | $133.39 | 1 |
| ABBVIE INC. | $66.93 | 2 |
| Paratek Pharmaceuticals, Inc. | $37.17 | 2 |
| Inari Medical, Inc. | $24.47 | 1 |
| Averitas Pharma Inc. | $13.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.90 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105039525 | CMS |
| ABBVIE INC. | $47.03 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105039527 | CMS |
| Amgen Inc. | $14.00 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115933657 | CMS |
| Amgen Inc. | $31.60 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115933667 | CMS |
| Amgen Inc. | $7.42 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115933673 | CMS |
| Amgen Inc. | $18.85 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115933678 | CMS |
| Amgen Inc. | $29.12 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115933683 | CMS |
| Amgen Inc. | $28.61 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115933695 | CMS |
| Amgen Inc. | $21.58 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115933701 | CMS |
| Averitas Pharma Inc. | $13.51 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133437155 | CMS |
| ConvaTec Inc. | $133.39 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151380373 | CMS |
| Inari Medical, Inc. | $24.47 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140142748 | CMS |
| Organogenesis Inc. | $34.23 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145439231 | CMS |
| Organogenesis Inc. | $26.67 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145439233 | CMS |
| Organogenesis Inc. | $105.49 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145439235 | CMS |
| Organogenesis Inc. | $9.24 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145439237 | CMS |
| Organogenesis Inc. | $33.99 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145439239 | CMS |
| Paratek Pharmaceuticals, Inc. | $23.84 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113910616 | CMS |
| Paratek Pharmaceuticals, Inc. | $13.33 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113910618 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.